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1. Introduction 
Dermatofibrosarcoma protuberans (DFSP) is best described as a fibroblastic neoplasm. It is a 
low to moderate grade type of soft tissue sarcoma (STS) arising from cells of mesenchymal 
origin in the dermal layer of the skin1-4. This entity was first described in 1924 by Darier and 
Ferrand5. Though DFSP is a low grade malignancy, fibrosarcomatous variant can be very 
aggressive especially when provoked by inadequate excision. It is a rare type of skin cancer 
that can grow deeply into the skin to invade the fat, muscle, and bone. DFSP is a locally 
aggressive tumour and rarely metastasizes. This gives it a higher survival rate when 
adequately excised1-7.  
In developing countries however, late presentation to hospitals are very common. Patients 
here seek help first from unqualified persons and only come to the specialists late into their 
illness. This has led to poor outcomes in many cases.  
2. Epidemiology 
DFSP comprises 0.01% of all malignant tumours and 2 – 6% of all soft tissue sarcomas1,2,3. 
STS constitute overall less than 1% of human adult solid malignant tumour7 but can be life 
threatening and sometimes difficult to diagnose and very challenging to treat. It has no sex 
predilection nor specified age incidence but is commoner between the ages of 20 and 50 
years6-8. It is stated to be commoner in blacks with an estimated incidence of 0.8 to 5 
per/million persons per year in America6,8.  
3. Aetiology  
The exact cause of Soft Tissue Sarcomas and Dermatofibrosarcoma Protuberans is not well 
known. Predisposing factors include genetic mutation of the P 53 gene, exposure to ionising 
radiations, post burn and other scars and exposure to certain carcinogens have been 
documented. Of particular note is its recurrent nature especially following inadequate  
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excision either in margin or depth. High rate recurrence is noted in developing countries 
like Nigeria3.  
4. Pathology 
DFSP are skin cancers that arise from the dermal fibroblasts. Recent evidences by 
immunohistochemical tests however suggest that they may arise from the dendritic cells in 
the skin  
It grows in a finger like manner into the surrounding tissues leading to uneven penetration. 
This is a major cause of recurrence as some malignant cells may have projected far beyond 
the macroscopic margin at the time of initial resection.  
DFSP is highly cellular and comprises spindle cells arranged in a radial fashion most 
characteristic at the periphery of the tumor. It displays immunoreactivity to CD34. 
Haematogenous spread to the lungs is the commonest route of metastasis, regional lymph 
nodes are rarely involved7. 
The variants of DFSP include the Bednar tumour, myxiod DFSP, atrophic type and the 
fibrosarcomatous variant which is very aggressive. 
There is no staging system yet developed specific for DFSP but it is currently staged in 
accordance with the American Musculoskeletal Tumour society staging system taking into 
account tumour grade and compartmentalization6.  
5. Clinical presentation 
The usual pattern is an initial painless slow growing tumour. It may remain indolent for 
many years and sometimes grow to a very large size (more than 5cm in diameter over a few 
years). It may ulcerate but more commonly the patient intervenes one way or the other. 
Inadequate excision lead to recurrence of larger tumour and sometimes very slow healing 
ulcer. In the developing countries, they usually present with very large often fungating 
recurrent tumours. Other symptoms then depend on local effects and its site of location.  
Metastasis is a late event and is commonest to the lung1,2,6,7,10. Later to liver, lymph nodes, 
peritoneum (for abdominal wall tumours) and nearby structures. Progression depends on 
the histological variant, grade, stage, size, how deeply seated the tumour is and presence or 
absence of other tumours and patients genetic predisposition. The immune status may also 
play a role as a rare recurrence of the fibrosarcomatous variant has been reported to occur in 
pregnancy11.  
Rate of recurrence depends on the adequacy of resection margin and other management 
modalities employed. A DFSP has been reported to occur at the surgical scar of an earlier 
excised tumour after many years12. 
Pain is as a result of pressure. When infected, there may be fever, anorexia and Weight 
loss. Overall, patient presents with large tumours without much constitutional 
symptoms/sign. 
6. Investigations 
Biopsy of all suspicious lesions is mandatory. Histological and immunochemistry studies 
are done. The investigative tool of choice is the magnetic resonance imaging (MRI). This is 
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capable of delineating tissues planes thereby detecting extent of invasion of surrounding 
tissues including muscles and fat. This diagnostic tool is usually not available in 
developing countries. CT scan and contrast enhanced studies aid the diagnosis. X Rays of 
the affected parts and chest for metastasis to the lungs are also indicated in many cases. 
Biopsy of all suspicious tissues is recommended and for all lesions more than 5cm in 
diameter, an incision biopsy should precede definitive resection for adequate planning to 
avoid the danger of inadequate excision. Other investigations are done to determine the 
extent of local spread, distant metastasis and effects of the tumour on the patient 
generally.   
7. Treatment 
Surgery is the main stay of treatment. Wide local excision with histologically negative 
margins is the cornerstone of treatment3,6. For tumour less than 5cm in diameter a 3cm 
margin is recommended and for lesions greater than 5cm and recurrent lesions resection 
margin should be 5cm. The underlying tissue is also excised beyond the normal plane. The 
margins are examined to ensure they are tumour-free. Adjuvant radiotherapy increases 
tumour clearance and decreases rate of recurrence. Resection of tumours close to 
neurovascular bundle, bone and other vital structures may not obey these rules and 
adjuvant radiotherapy and chemotherapy will then be absolutely indicated. It is usually 
difficult to identify the margin of the tumour macroscopically as the finger like projections 
into muscle, fascia, fat resemble normal tissue. Fibrosis from previous surgeries may also 
make adequate excision difficult. Radiotherapy and chemotherapy may be used pre-
operatively to downsize the tumour and make it more resectable or post-operatively to 
manage residual tumours and metastasis. 
Mohs micrographic surgery is presently employed (where available) and hold great promise 
for complete tumour excision7. Very large defects may be created after tumour excision 
which requires the services of a plastic reconstructive surgeon. When the limb is involved, 
limb sparing surgeries are first attempted where feasible otherwise amputation may be 
resorted to.  Reconstructive procedures include local rotation and advancement flaps, 
regional flaps, pedicle and free tissue transfers. Prosthetic mesh has been used for 
reconstructing full thickness abdominal /chest wall defects3,31,14. 
A multidisciplinary approach by healthcare team with experience in management of STS is 
recommended for proper treatment of DFSP. 
8. Follow up 
Follow up of the patient is for life. Tumours have been known to recur many years after 
adequate excision. Any suspicious lesion around the area of an initial excision including the 
scars is subjected to full investigations and expert care. 
9. Prognosis 
Prognosis depends on both tumour and patient factors as well as availability of investigative 
and support services. Size is an important prognostic variable and so affects the quality of  
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Fig. 1. Recurrence in pregnancy after 3rd excision, now very aggressive and fatal.resection.  
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In developed countries, the prognosis has improved remarkably but in the developing 
world however, prognosis remain poor due to a variety of factors. These include poverty, 
ignorance, late presentation with very large often fungating and metastatic lesions, low 
infrastructure and low availability of expertise. 
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Soft tissue tumors include a heterogeneous group of diagnostic entities, most of them benign in nature and
behavior. Malignant entities, soft tissue sarcomas, are rare tumors that account for1% of all malignancies.
These are predominantly tumors of adults, but 15% arise in children and adolescents. The wide biological
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whether a soft tissue mass is benign or malignant is vital for appropriate management. This book is the result
of collaboration between several authors, experts in their fields; they succeeded in translating the complexity of
soft tissue tumors and the diversity in the diagnosis and management of these tumors.
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